UroGen Pharma Correlations

URGN Stock

USD 12.70 0.04 0.32%

The current 90-days correlation between UroGen Pharma and Eliem Therapeutics is -0.14 (i.e., Good diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as UroGen Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if UroGen Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

UroGen Pharma Correlation With Market

Weak diversification

The correlation between UroGen Pharma and DJI is 0.37 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding UroGen Pharma and DJI in the same portfolio, assuming nothing else is changed.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in UroGen Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

To learn how to invest in UroGen Stock, please use our How to Invest in UroGen Pharma guide.

Moving together with UroGen Stock

0.62	HLN	Haleon plc	Pair Corr
0.71	JNJ	Johnson Johnson Sell-off Trend	Pair Corr
0.71	LLY	Eli Lilly	Pair Corr
0.81	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.71	RDY	Dr Reddys Laboratories	Pair Corr
0.76	TAK	Takeda Pharmaceutical	Pair Corr
0.63	LTRN	Lantern Pharma	Pair Corr
0.67	AMGN	Amgen Inc	Pair Corr
0.65	ANRO	Alto Neuroscience,	Pair Corr
0.82	SIGA	SIGA Technologies	Pair Corr

Moving against UroGen Stock

0.71	BMY	Bristol Myers Squibb Sell-off Trend	Pair Corr
0.7	EWTX	Edgewise Therapeutics	Pair Corr
0.68	BHC	Bausch Health Companies	Pair Corr
0.67	GILD	Gilead Sciences	Pair Corr
0.56	ESPR	Esperion Therapeutics Buyout Trend	Pair Corr
0.52	GANX	Gain Therapeutics	Pair Corr
0.42	WAT	Waters	Pair Corr
0.4	VTRS	Viatris	Pair Corr
0.4	EBS	Emergent Biosolutions	Pair Corr
0.72	BSX	Boston Scientific Corp Sell-off Trend	Pair Corr
0.43	CPRX	Catalyst Pharmaceuticals	Pair Corr
0.4	ABT	Abbott Laboratories Sell-off Trend	Pair Corr
0.38	DXCM	DexCom Inc Sell-off Trend	Pair Corr
0.34	MNMD	Mind Medicine	Pair Corr

Related Correlations Analysis

	ELYM	INBX	MACK	CELC	ELVN	IKNA	XLO	TARA	SRRK	VACC
ELYM		0.36	0.7	0.32	-0.62	-0.33	-0.6	-0.71	-0.81	0.3	ELYM
INBX	0.36		0.5	0.44	0.12	0.04	0.03	-0.11	-0.08	-0.04	INBX
MACK	0.7	0.5		0.5	-0.05	-0.13	-0.45	-0.74	-0.52	0.41	MACK
CELC	0.32	0.44	0.5		0.24	0.08	-0.02	-0.35	-0.17	0.38	CELC
ELVN	-0.62	0.12	-0.05	0.24		0.33	0.42	0.21	0.71	-0.03	ELVN
IKNA	-0.33	0.04	-0.13	0.08	0.33		0.24	0.31	0.31	-0.2	IKNA
XLO	-0.6	0.03	-0.45	-0.02	0.42	0.24		0.75	0.55	-0.52	XLO
TARA	-0.71	-0.11	-0.74	-0.35	0.21	0.31	0.75		0.63	-0.67	TARA
SRRK	-0.81	-0.08	-0.52	-0.17	0.71	0.31	0.55	0.63		-0.33	SRRK
VACC	0.3	-0.04	0.41	0.38	-0.03	-0.2	-0.52	-0.67	-0.33		VACC
	ELYM	INBX	MACK	CELC	ELVN	IKNA	XLO	TARA	SRRK	VACC

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

TARA	+ 0.75	XLO
SRRK	+ 0.71	ELVN
MACK	+ 0.7	ELYM
SRRK	+ 0.63	TARA
SRRK	+ 0.55	XLO
MACK	+ 0.5	INBX

High negative correlations

SRRK	- 0.81	ELYM
TARA	- 0.74	MACK
TARA	- 0.71	ELYM
VACC	- 0.67	TARA
ELVN	- 0.62	ELYM
XLO	- 0.6	ELYM

Risk-Adjusted Indicators

There is a big difference between UroGen Stock performing well and UroGen Pharma Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze UroGen Pharma's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
ELYM	3.87	(0.72)	0.00	0.69	0.00	0.00	6.21	(9.35)	34.87
INBX	2.31	0.09	0.02	0.26	2.72	(2.81)	5.54	(6.11)	16.80
MACK	0.78	(0.06)	0.00	3.64	0.00	0.00	1.89	(1.74)	7.02
CELC	2.27	(0.51)	0.00	(0.29)	0.00	0.00	4.55	(5.83)	16.97
ELVN	2.01	0.03	0.01	0.16	2.18	(2.29)	5.84	(4.07)	12.96
IKNA	0.93	(0.08)	0.00	(0.02)	0.00	0.00	1.81	(1.74)	5.87
XLO	5.52	0.74	0.09	49.32	5.98	(7.03)	10.81	(9.03)	57.76
TARA	3.34	0.69	0.18	5.54	2.72	(4.49)	8.67	(4.98)	19.48
SRRK	11.85	6.57	1.11	(0.69)	3.22	(15.32)	10.34	(6.99)	375.97
VACC	1.84	(0.11)	0.00	0.72	0.00	0.00	3.36	(4.63)	14.02

UroGen Pharma Corporate Management

Dong Kim	Chief Officer	Profile
Jason JD	Chief Counsel	Profile
Sari PrutchiSagiv	Marketing Director	Profile
Jason Smith	Chief Counsel	Profile
Bryon Wornson	Advocacy Talent	Profile
Eric Zanten	Director Communications	Profile
Christopher CPA	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC